PHILADELPHIA — (September 17th, 2024) — The Wistar Institute’s President and CEO, Dario C. Altieri, M.D., and team have demonstrated the role of Parkin — a protein implicated in Parkinson’s disease —…
PHILADELPHIA — (July 25, 2024) — The Wistar Institute honors 2023 Nobel Prize laureate in Physiology or Medicine Katalin Karikó, Ph.D., as the 2024 Helen Dean King Award recipient. Dr. Karikó, profes…
The Wistar Institute — building on its history of leading advances in human health as the nation’s first nonprofit biomedical research institute — is creating a new HIV Cure and Viral Diseases Center…
PHILADELPHIA — (July 10th, 2024) —On Tuesday, July 16th at 6:30 pm EDT, Nobel Laureate in Medicine or Physiology Drew Weissman, M.D., Ph.D., — Roberts Family Professor in Vaccine Research, Director o…
PHILADELPHIA — (July 10, 2024) — The Wistar Institute (“Wistar”) is pleased to announce a research collaboration with Accelerated Biosciences Corp. (“Accelerated Bio”) aimed at creating a groundbreak…
PHILADELPHIA — (July 1, 2024) —The Wistar Institute is pleased to announce the appointment of Jozef Madzo, Ph.D., to the faculty as an assistant professor and Director of Bioinformatics. Dr. Madzo wi…
PHILADELPHIA — (June 18, 2024) — The Wistar Institute received a $10 million donation from an anonymous donor who previously committed $20 million to support Wistar’s new Center for Advanced Therapeu…
PHILADELPHIA — (June 04, 2024) — Advanced clear cell renal cell carcinoma (ccRCC) is a deadly form of kidney cancer with few treatment options; even with new immunotherapies, only around one in 10 pa…
